Repository of University of Nova Gorica

Show document
A+ | A- | Help | SLO | ENG

Title:Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma Patient Derived Xenografts
Authors:ID Crepin, Ronan, Institut Curie (Author)
ID Gentien, David, Institut Curie (Author)
ID Duche, Angeline, Institut Curie (Author)
ID Rapinat, Audrey, Institut Curie (Author)
ID Reyes, Cecile, Institut Curie (Author)
ID Nemati, Fariba, Institut Curie (Author)
ID Massonnet, Gerald, Institut Curie (Author)
ID Deacaudin, Didier, Institut Curie (Author)
ID Djander, Selma, Institut Curie (Author)
ID Moutel, Sandrine, Institut Curie (Author)
ID Desrumeaux, Klervi Even, Institut Curie (Author)
ID Cassoux, Nathalie, Institut Curie (Author)
ID Piperno-Neumann, Sophie, Institut Curie (Author)
ID Amigorena, Sebastian, Institut Curie (Author)
ID Perez, Franck, Institut Curie (Author)
ID Roman-Roman, Sergio, Institut Curie (Author)
ID De Marco, Ario, UNG (Author)
Files: This document has no files that are freely available to the public. This document may have a physical copy in the library of the organization, check the status via COBISS. Link is opened in a new window
Language:English
Work type:Not categorized
Typology:1.01 - Original Scientific Article
Organization:UNG - University of Nova Gorica
Abstract:Monoclonal antibodies specific for biomarkers expressed on the surface of uveal melanoma (UM) cells would simplify the immune-capture and genomic characterization of heterogeneous tumor cells originated from patient derived xenografts (PDXs). Antibodies against four independent tumor antigens were isolated by panning a nanobody synthetic library. Such antibodies enabled flow-cytometry-based sorting of distinct cell sub-populations from UM PDXs and to analyze their genomic features. The complexity and specificity of the biochemical and genomic biomarker combinations mirrored the UM tumor polyclonality. The data showed that MUC18 is highly and universally displayed at the surface of UM cells with different genetic background and consequently represents a reliable pan-biomarker for their identification and purification. In contrast, the other three biomarkers were detected in very variable combinations in UM PDX cells. The availability of the identified nanobodies will be instrumental in developing clone-specific drug evaluation and rational clinical strategies based on accurate genomic profiling
Keywords:nanobodies, uveal melanoma, patient derived xenografts, MUC18, membrane surface biomarkers, panning, tumor polyclonality
Publication version:Version of Record
Year of publishing:2017
Number of pages:11
Numbering:30
PID:20.500.12556/RUNG-3064-55912669-33a0-6520-c8d7-18453b1b60b4 New window
COBISS.SI-ID:4768763 New window
DOI:10.1111/pcmr.12577 New window
NUK URN:URN:SI:UNG:REP:TFTBEVVZ
Publication date in RUNG:19.04.2017
Views:5671
Downloads:0
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Pigment Cell and Melanoma Research
Publisher:Wiley: 12 months
Year of publishing:2017
ISSN:1755-1471

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:19.04.2017

Back